Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRights &iss. Regulatory News (RIII)

Share Price Information for Rights &iss. (RIII)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,180.00
Bid: 2,180.00
Ask: 2,220.00
Change: 0.00 (0.00%)
Spread: 40.00 (1.835%)
Open: 2,180.00
High: 2,220.00
Low: 2,180.00
Prev. Close: 2,200.00
RIII Live PriceLast checked at -
Rights & Issues is an Investment Trust

To exceed the benchmark index over the long term whilst managing risk by investing in equities with an emphasis on smaller companies, UK smaller companies will normally constitute at least 80% of the investment portfolio.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Rights and Issues Investment Trust PLC: Share Buyback Programme Extension

1 Aug 2023 14:42

Rights and Issues Investment Trust PLC (RIII) Rights and Issues Investment Trust PLC: Share Buyback Programme Extension 01-Aug-2023 / 14:41 GMT/BST


Rights and Issues Investment Trust plc

LEI: 2138002AWAM93Z6BP574

12 month Share Repurchase Programme in accordance with Discount Management Policy

Rights and Issues Investment Trust plc (the “Company”) announces that the share repurchase programme announced on 9 August 2021 and extended to 31 July 2023 has been extended for a further 12 months to 31 July 2024. finnCap has been authorised to repurchase ordinary shares of 25p each (“Shares”) on its behalf and within certain pre-set parameters between 1 August 2023 and 31 July 2024 (the “Buy-Back Period”).

The Directors of the Company confirm that they are satisfied that all inside information known to the Directors and the Company up to the date of this notice has been notified to a Regulated Information Service (“RIS”). Accordingly, the Company is not prohibited from granting this authority to finnCap under the Corporate Broking Agreement.

Purchases of Shares during the Buy-Back Period shall be subject to the following overriding restrictions:

the maximum number of Shares acquired shall not, in aggregate, exceed the authorities granted at the Company’s annual general meeting in 2023 and anticipated to be sought from shareholders at the Company’s annual general meeting in 2024. In the event that shareholders do not authorise the Directors to purchase shares in 2024 the share repurchase programme shall terminate immediately; the maximum value of Shares acquired during the Buy-Back Period shall not, in aggregate, exceed £1.0 million per calendar month (and pro rata for part months). However, to the extent that the value of Shares acquired in any month (or part month) is lower than the maximum value for that month, such excess capacity shall be carried forward to the following month and increase the maximum value for the following month accordingly, and so on for subsequent months. For the avoidance of doubt, there shall be no limit to the number of times an excess can be carried forward, or the total amount of such excess; the maximum price paid per Share shall be no more than the highest of: (i) 105% of the average middle market closing prices of the Shares for the 5 dealing days preceding the date of such purchase; (ii) the last independent trade price; and (iii) the highest current independent bid for the Shares when the purchase is carried out; the price paid per Share shall not be more than 95 per cent. of finnCap’s estimate of the net asset value per Share of the Company at the time of each purchase; and no purchases are to be made on any dealing day when the Company appears on the Disclosure Table published by the Panel on Takeovers and Mergers.

The Company shall not (i) exercise any influence over how, when or whether finnCap effects share repurchases or (ii) change the number of Shares, price or timing of the purchases.

Enquiries:

finnCap Limited 

William Marle / George Dollemore – Corporate Finance  +44 (0) 20 7220 0500

Mark Whitfeld / Pauline Tribe – Sales  +44 (0) 20 7220 0500

 

Apex Fund Administration Services (UK) Limited

cosec@maitlandgroup.com  +44 (0) 1245 398950


Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.
ISIN:GB0007392078
Category Code:MSCM
TIDM:RIII
LEI Code:2138002AWAM93Z6BP574
Sequence No.:261669
EQS News ID:1693373
 
End of AnnouncementEQS News Service

UK Regulatory announcement transmitted by EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
3rd May 20244:53 pmRNSTransaction in Own Shares
3rd May 202411:19 amRNSNet Asset Value(s)
2nd May 202410:37 amRNSNet Asset Value(s)
1st May 202412:39 pmRNSNet Asset Value(s)
1st May 20247:00 amRNSTotal Voting Rights
30th Apr 20245:34 pmRNSTransaction in Own Shares
30th Apr 202410:27 amRNSNet Asset Value(s)
29th Apr 20244:47 pmRNSTransaction in Own Shares
29th Apr 202410:42 amRNSNet Asset Value(s)
26th Apr 202410:52 amRNSNet Asset Value(s)
25th Apr 202412:12 pmRNSNet Asset Value(s)
24th Apr 20243:12 pmRNSNet Asset Value(s)
23rd Apr 20245:08 pmRNSTransaction in Own Shares
23rd Apr 202410:28 amRNSNet Asset Value(s)
22nd Apr 202411:14 amRNSNet Asset Value(s)
19th Apr 20244:49 pmRNSTransaction in Own Shares
19th Apr 202411:16 amRNSNet Asset Value(s)
18th Apr 202410:29 amRNSNet Asset Value(s)
17th Apr 202410:51 amRNSNet Asset Value(s)
16th Apr 202411:54 amRNSNet Asset Value(s)
15th Apr 202411:37 amRNSNet Asset Value(s)
12th Apr 20244:54 pmRNSTransaction in Own Shares
12th Apr 202410:40 amRNSNet Asset Value(s)
11th Apr 202410:34 amRNSNet Asset Value(s)
10th Apr 202412:29 pmRNSNet Asset Value(s)
9th Apr 202411:02 amRNSNet Asset Value(s)
8th Apr 20245:00 pmRNSTransaction in Own Shares
8th Apr 202411:17 amRNSNet Asset Value(s)
5th Apr 202411:37 amRNSNet Asset Value(s)
4th Apr 20244:53 pmRNSTransaction in Own Shares
4th Apr 202411:46 amRNSNet Asset Value(s)
3rd Apr 202410:40 amRNSNet Asset Value(s)
2nd Apr 20244:58 pmRNSTransaction in Own Shares
2nd Apr 20241:00 pmRNSNet Asset Value(s)
2nd Apr 20247:00 amRNSTotal Voting Rights
28th Mar 20244:59 pmRNSTransaction in Own Shares
28th Mar 202410:13 amRNSNet Asset Value(s)
27th Mar 20244:35 pmRNSChange of Adviser
27th Mar 20244:32 pmRNSResult of AGM
27th Mar 202411:43 amRNSNet Asset Value(s)
26th Mar 20246:00 pmRNSTransaction in Own Shares
26th Mar 202410:22 amRNSNet Asset Value(s)
25th Mar 202411:53 amRNSNet Asset Value(s)
22nd Mar 202410:43 amRNSNet Asset Value(s)
21st Mar 20249:42 amRNSNet Asset Value(s)
20th Mar 202410:54 amRNSNet Asset Value(s)
19th Mar 202410:23 amRNSNet Asset Value(s)
18th Mar 202410:43 amRNSNet Asset Value(s)
15th Mar 202410:41 amRNSNet Asset Value(s)
14th Mar 20244:52 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.